Trial Profile
Safety and efficacy of pemafibrate combined with statins in Japanese patients with dyslipidemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Feb 2016
Price :
$35
*
At a glance
- Drugs Pemafibrate (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions; Therapeutic Use
- 15 Feb 2016 New trial record